Skip to main content
Clinical Trials/CTRI/2020/06/026056
CTRI/2020/06/026056
Not yet recruiting
Phase 3

A prospective interventional study on the effect of Arsenicum album 30 C as a prophylactic measure among High risk population exposed to COVID-19. - ARCOV

Ministry of AYUSH0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ministry of AYUSH
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects of high risk population.
  • 2\. Male or female subjects above the age of 03 years to 65 years.
  • 3\. Subject who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.

Exclusion Criteria

  • 1\. Pregnant and Lactating woman.
  • 2\. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening.
  • 3\. Subjects who are on any other regular medication( Alternative/ Modern)for any other ailments.
  • 4\. Subjects participating in any other clinical study or having participated in any other study one month prior to screening in the present study.
  • 5\. Subjects having a past history of allergy to any medicine that is part of the Homoeopathic
  • intervention. Other conditions, which in the opinion of the investigators, makes the patient
  • unsuitable for enrolment or could interfere with his participation in, and completion of the protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials